Serum Institute To Start Phase 3 Trials Of COVID-19 Vaccine Covovax By Mid-May

New Delhi, May 04: Serum Institute of India is likely to start phase 3 trials of COVID-19 vaccine Covovax, which it is making in partnership with American company Novavax, by mid-may.

The Drugs Controller General of India has provided its approval to go for the next phase trials.

Covovax is the second vaccine candidate after Covishield that SII is manufacturing.

Dr Abhijit Kadam, Scientist C, coordinating principal investigator from ICMR-National AIDS Research Institute of the trial, said that tentatively phase-3 should start by mid-May. 



Cross Town News is the no. 1 Weekly Newspaper and Online News Portal in J&K in term of serious News. The rugged Newspaper & Portal is with a substantial difference to read and presence to feel. This newspaper has a vision to deliver the real side of truth to the public . Since it’s inception in 2013 March, It has become No. 1 News medium for people of J&K. Cross Town News has a mission to deliver high quality news across the nation within fraction of time.

Subscribe Now

Subscribe to our weekly Newsletter.